Karina Tin, Author at The Column Group

Dr. Dan Nomura joins The Column Group as iPartner

The Column Group announced the recruitment of Dr. Dan Nomura to the firm’s renowned group of iPartners. Dr. Nomura is a Professor of Chemical Biology and Molecular Therapeutics in the Department of Chemistry and the Department of Molecular and Cell Biology in the Division of Molecular Therapeutics at the University of California, Berkeley and an

Dr. Dan Nomura joins The Column Group as iPartner Read More »

Karina Tin

Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer

Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update

Dr. Dan Nomura joins The Column Group as iPartner

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

Carmot Therapeutics Highlights Clinical Data from its Pipeline of Treatments for Obesity and Diabetes at the 83rd American Diabetes Association Scientific Sessions

Escient Pharmaceuticals Announces Positive Results From Phase 1 Study of EP262, A First-In-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders

Neurona Therapeutics Presents One-Year Data on the First Patient Treated with NRTX-1001 Cell Therapy in an Ongoing Phase I/II Trial for Drug-resistant Focal Epilepsy

Nurix Therapeutics Presents Data from Studies of Its Targeted Protein Degraders in B Cell Malignancies and Initiates Expansion of NX-2127 Phase 1b Trial in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma Indications

Effector Therapeutics Raises a Total of $16.2M in Gross Proceeds From Two Recent Registered Direct Offerings

Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke